CMS Will “Walk Through” Medicare Drug Plan Applications Dec. 13
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will highlight “critical elements” that prospective Part D drug plan applicants should consider during an “open door” forum teleconference. CMS also will review its draft guidelines for evaluating PDP formularies.
You may also be interested in...
Medicare P&Ts Would Follow Pharmacist Groups’ Principles Under CMS Draft
Pharmacy & therapeutics committee principles developed by the American Society of Health System Pharmacists and Academy of Managed Care Pharmacy will serve as guidelines for Part D drug plans, CMS draft formulary guidelines say. The guidelines also list standards CMS will use in approving formularies.
House Appropriations Subcommittee Plans FDA Hearing July 26
Ag/FDA subcommittee had tabled FDA hearing pending confirmation of a permanent agency commissioner. House cleared FDA 2006 spending in early June.
Second Quarter Earnings Season Heats Up
Amgen, J&J, Sanofi-Aventis, Pfizer, Merck, Roche, Lilly and Schering-Plough are scheduled to report results in upcoming week. Bristol could expand upon plans to sell OTC unit to Novartis the following week.